 |
 |

Effect of Long-Acting OROS Methylphenidate on Routine Driving in Young Adults With Attention-Deficit/Hyperactivity Disorder
Daniel J. Cox, PhD;
Amori Yee Mikami, PhD;
Brian S. Cox, BS;
Margaret Taylor Coleman, BA;
Aamir Mahmood, MD;
Ajay Sood, MD;
Melissa Moore, MD;
Roger Burket, MD;
R. Lawrence Merkel, MD, PhD
Arch Pediatr Adolesc Med. 2008;162(8):793-794.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
Young drivers with attention deficit/hyperactivity disorder (ADHD), because of their inattention and impulsivity, have more vehicular collisions, citations, and related injuries than drivers without ADHD.1 In laboratory studies, methylphenidate has improved simulated driving in this population.2 However, it is unknown whether long-acting methylphenidate improves routine driving while youth negotiate cell phones, music systems, teenaged passengers, and rushed schedules.
We report on the routine driving safety of 2 young drivers who at the time of recruitment were not taking ADHD medication. However, 2 years previously they participated in a laboratory study2 in which they responded to 72 mg of osmotic-release oral system (OROS) methylphenidate hydrochloride daily.
Methods
After signing a consent form approved by our institutional review board, study . . . [Full Text of this Article] Results
Comment
AUTHOR INFORMATION
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|